Mass spectrometry-based protein assays for in vitro diagnostic testing

References

• Kuzyk MA, Smith D, Yang J et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell Proteomics8(8), 1860–1877 (2009).
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Abbatiello SE et al. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol. Cell Proteomics10(4), M110 005645 (2011).
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell Proteomics9(1), 184–196 (2010).
   PubMed Web of Science ®Google Scholar
• Agger SA, Marney LC, Hoofnagle AN. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. Clin. Chem.56(12), 1804–1813 (2010).
   PubMed Web of Science ®Google Scholar
• Kiernan UA, Phillips DA, Trenchevska O, Nedelkov D. Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variants. PLoS One6(3), e17282 (2011).
   PubMed Web of Science ®Google Scholar
• Kumar V, Barnidge DR, Chen LS et al. Quantification of serum 1–84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin. Chem.56(2), 306–313 (2010).
   PubMed Web of Science ®Google Scholar
• Lopez MF, Rezai T, Sarracino DA et al. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clin. Chem.56(2), 281–290 (2010).
   PubMed Web of Science ®Google Scholar
• Trenchevska O, Kamcheva E, Nedelkov D. Mass spectrometric immunoassay for quantitative determination of protein biomarker isoforms. J. Proteome Res.9(11), 5969–5973 (2010).
   PubMed Web of Science ®Google Scholar
• Trenchevska O, Nedelkov D. Targeted quantitative mass spectrometric immunoassay for human protein variants. Proteome Sci.9(1), 19 (2011).
   PubMed Web of Science ®Google Scholar
• Saudek CD, Brick JC. The clinical use of hemoglobin A1c. J. Diabetes Sci. Technol.3(4), 629–634 (2009).
   PubMedGoogle Scholar
• Nedelkov D. Mass spectrometry-based immunoassays for the next phase of clinical applications. Expert. Rev. Proteomics3(6), 631–640 (2006).
   PubMed Web of Science ®Google Scholar
• Nelson RW, Krone JR, Bieber AL, Williams P. Mass-spectrometric immunoassay. Anal. Chem.67(7), 1153–1158 (1995).
   PubMed Web of Science ®Google Scholar
• Niederkofler EE, Kiernan UA, O’Rear J et al. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circ. Heart Fail.1(4), 258–264 (2008).
   PubMed Web of Science ®Google Scholar
• Nedelkov D. Population proteomics: addressing protein diversity in humans. Expert Rev. Proteomics2(3), 315–324 (2005).
   PubMed Web of Science ®Google Scholar
• Grubb AO. Cystatin C – properties and use as diagnostic marker. Adv. Clin. Chem.35, 63–99 (2000).
   PubMed Web of Science ®Google Scholar
• Henskens YM, Veerman EC, Nieuw Amerongen AV. Cystatins in health and disease. Biol. Chem. Hoppe Seyler377(2), 71–86 (1996).
   PubMed Web of Science ®Google Scholar
• Reed CH. Diagnostic applications of Cystatin C. Br. J. Biomed. Sci.57(4), 323–329 (2000).
   PubMed Web of Science ®Google Scholar
• Randers E, Erlandsen EJ. Serum Cystatin C as an endogenous marker of the renal function – a review. Clin. Chem. Lab. Med.37(4), 389–395 (1999).
   PubMed Web of Science ®Google Scholar
• Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum Cystatin C as a marker of the renal function. Scand. J. Clin. Lab. Invest.58(7), 585–592 (1998).
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Kwon C, Stevens G. Serum Cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis.40(2), 221–226 (2002).
   PubMed Web of Science ®Google Scholar
• Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin. Chem.48(5), 699–707 (2002).
   PubMed Web of Science ®Google Scholar
• Li J, Dunn W, Breaud A, Elliott D, Sokoll LJ, Clarke W. Analytical performance of 4 automated assays for measurement of Cystatin C. Clin. Chem.56(8), 1336–1339 (2010).
   PubMed Web of Science ®Google Scholar
• Trenchevska O, Kamcheva E, Nedelkov D. Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants. Proteomics11(18), 3633–3641 (2011).
   PubMed Web of Science ®Google Scholar
• Erlandsen EJ, Randers E, Kristensen JH. Reference intervals for serum Cystatin C and serum creatinine in adults. Clin. Chem. Lab. Med.36(6), 393–397 (1998).
   PubMed Web of Science ®Google Scholar
• Asgeirsson B, Haebel S, Thorsteinsson L et al. Hereditary Cystatin C amyloid angiopathy: monitoring the presence of the Leu-68–>Gln Cystatin C variant in cerebrospinal fluids and monocyte cultures by MS. Biochem. J.329(Pt 3), 497–503 (1998).
   PubMed Web of Science ®Google Scholar
• Grubb A, Lofberg H. Human γ-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc. Natl Acad. Sci. USA79(9), 3024–3027 (1982).
   PubMed Web of Science ®Google Scholar
• Nedelkov D, Phillips DA, Tubbs KA, Nelson RW. Investigation of human protein variants and their frequency in the general population. Mol. Cell Proteomics6(7), 1183–1187 (2007).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res.3(2), 235–244 (2004).
   PubMed Web of Science ®Google Scholar
• Kim K, Kim Y. Preparing multiple-reaction monitoring for quantitative clinical proteomics. Expert Rev. Proteomics6(3), 225–229 (2009).
   PubMed Web of Science ®Google Scholar
• Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci.877(13), 1229–1239 (2009).
   PubMed Web of Science ®Google Scholar
• Yocum AK, Chinnaiyan AM. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry. Brief Funct. Genomic. Proteomic.8(2), 145–157 (2009).
   PubMedGoogle Scholar
• Cho WC. Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome. Expert Rev. Proteomics8(1), 1–4 (2011).
   PubMed Web of Science ®Google Scholar
• Li J, Kelm KB, Tezak Z. Regulatory perspective on translating proteomic biomarkers to clinical diagnostics. J. Proteomics74(12), 2682–2690 (2011).
   PubMed Web of Science ®Google Scholar